关注
Noeman Ardalan
Noeman Ardalan
Department of biology, College of science, Science and Research Branch, Islamic Azad University
在 srbiau.ac.ir 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Novel mutant of Escherichia coli asparaginase II to reduction of the glutaminase activity in treatment of acute lymphocytic leukemia by molecular dynamics simulations and QM-MM …
N Ardalan, S Mirzaie, AA Sepahi, RA Khavari-Nejad
Medical hypotheses 112, 7-17, 2018
452018
Molecular docking and binding study of harpagoside and harpagide as novel anti-inflammatory and anti-analgesic compound from Harpagophytum procumbens based on their …
A Rahimi, K Razmkhah, M Mehrnia, A Mohamadnia, H Sahebjamee, ...
Asian Pacific Journal of Tropical Disease 6 (3), 227-231, 2016
282016
Blockage of the monoamine oxidase by a natural compound to overcome parkinson’s disease via computational biology
M Sherafatizangeneh, C Farshadfar, N Mojahed, A Noorbakhsh, ...
Journal of Computational Biophysics and Chemistry 21 (03), 373-387, 2022
172022
Development of Escherichia coli asparaginase II for the Treatment of Acute Lymphocytic Leukemia: In Silico Reduction of asparaginase II Side Effects by a Novel Mutant (V27F)
N Ardalan, A Akhavan Sepahi, RA Khavari-Nejad
Asian Pacific Journal of Cancer Prevention 22 (4), 1137-1147, 2021
162021
Designing a natural inhibitor against human kynurenine aminotransferase type II and a comparison with PF-04859989: a computational effort against schizophrenia
A Noorbakhsh, E Hosseininezhadian Koushki, C Farshadfar, N Ardalan
Journal of Biomolecular Structure and Dynamics 40 (15), 7038-7051, 2022
132022
Prevention of SARS-CoV-2 proliferation with a novel and potent main protease inhibitor by docking, ADMET, MM-PBSA, and molecular dynamics simulation
A Noorbakhsh, RH Askandar, MS Alhagh, C Farshadfar, SH Seyedi, ...
Journal of Computational Biophysics and Chemistry 20 (03), 305-322, 2021
102021
The SARS-Cov-2 Proliferation blocked by a novel and potent main protease inhibitor via computer-aided drug design
S Shayan, S Jamaran, RH Askandar, A Rahimi, A Elahi, C Farshadfar, ...
Iranian Journal of Pharmaceutical Research: IJPR 20 (3), 399, 2021
82021
Prevalence of human T-lymphotropicvirus types I&II among high risk groups in Sanandaj in 2010.
N Ardalan, M Abdi, BR Zarif, A Amini, F Memary, E Haydari, A Ahmadi
72013
Structural screening into the recognition of a potent inhibitor against non-structural protein 16: a molecular simulation to inhibit SARS-CoV-2 infection
SH Seyedi, MS Alhagh, M Ahmadizad, N Ardalan, ...
Journal of Biomolecular Structure and Dynamics 40 (24), 14115-14130, 2022
42022
Risk factors associated with community-acquired CTX-M producing Klebsiella pneumoniae typing by Rep-PCR in Sanandaj, Iran
N Ardalan, S Jamaran, F Memari, K Davari, B Rostami, R Ramazanzadeh
Biotech Res Asia 13 (3), 1311-7, 2016
22016
Early Blockage of Mycobacterium Tuberculosis Cell-wall Synthesis via EchA\6 Inhibition to Overcome Resistance Strain: Insights from Umbrella Sampling Simulations
RH Askandar, F Sharifi, S Shayan, H Mohammadi, A Rahimi, N Ardalan, ...
Current Bioactive Compounds 19 (10), 2-17, 2023
12023
系统目前无法执行此操作,请稍后再试。
文章 1–11